Logotype for Brookfield Business Partners L.P.

Brookfield Business Partners (BBU) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Brookfield Business Partners L.P.

Q2 2024 earnings summary

8 Jul, 2026

Executive summary

  • Net loss attributable to unitholders for Q2 2024 was $20 million ($0.10 per unit), an improvement from a $48 million loss ($0.22 per unit) in Q2 2023, with results impacted by one-time events including a cybersecurity incident and project-related costs.

  • Adjusted EBITDA for Q2 2024 was $524 million, down from $606 million in Q2 2023, mainly due to lower contributions from Infrastructure and Business Services after asset sales.

  • Strong performance in advanced energy storage and offshore oil services was partially offset by lower volumes in engineered components and costs from a cybersecurity incident.

  • Major asset sales included the Canadian aggregates production operation and the road fuels operation, with the latter completed post-quarter end.

  • Continued progress on value creation initiatives, monetizing mature operations, and recycling capital to support growth.

Financial highlights

  • Q2 2024 revenues were $11.95 billion, down 12% year-over-year, reflecting business dispositions and lower volumes in key segments.

  • Adjusted EFO for Q2 2024 was $289 million, up from $185 million in Q2 2023, driven by gains on asset dispositions and public securities sales.

  • Interest expense decreased by $154 million in Q2 and $223 million year-to-date, driven by lower borrowings and refinancing.

  • Liquidity at quarter-end was approximately $1.6 billion, including $91 million in cash and $1.5 billion in available credit.

  • Quarterly distribution declared at $0.0625 per unit, payable September 27, 2024.

Outlook and guidance

  • Management expects earnings to improve as one-time items subside and continues to focus on value creation and capital recycling.

  • Expectation that one-time impacts from the CDK cyber incident and construction delays will not materially affect future quarters.

  • Anticipate market recovery in certain segments, such as DexKo, towards the end of 2024 and into 2025.

  • Encouraged by progress on strategic alternatives for Clarios, including IPO and other options.

  • Recent asset sales and refinancings are expected to support ongoing liquidity and operational flexibility.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more